Page History

...

Expand

title	tx.xpt (trial sets)

Treatment Duration will be controlled? During CT definition/reviews will need to decide appropriate Treatment duration values; For now, we just include good example values based on our experience

Row	STUDYID	ASSAYID	DOMAIN	SETCD	TXPARMCD	TXPARM	TXVAL
1	123	MNvit	TX	A1	METACT	Metabolic Activation (should there be two parms? Presence, type)?	+S9
2	123	MNvit	TX	A1	TRTDRTRG	Treatment Duration target. (how do we show 3-6 hour range? start/end, target and tolerance?, one text field not-analyzable)	3

					TRTDRTOL	Treatment Duration Tolerance
					TRTDURU	Treatment Duration Unit (this is for both TRTDURT, TRTDURTOL)	H
					INTRVN	name of the intervention article	Bleomycin or Cyclophosphamid A
					ITVTYPE	type of intervention article	choices of values: product; negative control; positive control
3	123	MNvit	TX	A1	PRDCONCITVCONC	Concentration of producti a	0
4	123	MNvit	TX	A1	PRDCONCUITVCONCU	Concentration Unit	ug/ml
5	123	MNvit	TX	A1	Product	Product Name
6	123	MNvit	TX	A1		Smoking Regime
7	123	MNvit	TX	A1		Smoke Fraction
	123	MNvit	TX	A2	METACT	Metabolic Activation	+S9
	123	MNvit	TX	A2	TRTDUR	Treatment Duration	Short Term
	123	MNvit	TX	A2	PRDCONC	Concentration of product	1250
	123	MNvit	TX	A2	PRDCONCU	Concentration Unit	ug/ml
	123	MNvit	TX	A2	Product	Product Name
	123	MNvit	TX	A2		Smoking Regime
	123	MNvit	TX	A2		Smoke Fraction
				A6	METACT
					TRTDUR
					INTRVN	name of the intervention article	Cyclophosphamid A
					ITVTYPE	type of intervention article	Positive control
					ITVCONC	Concentration of i a	5
				A6	ITVCONCU	Concentration Unit	ug/ml
				A6	TCNTL
	123	MNvit	TX	B1	METACT	Metabolic Activation	-S9
	123	MNvit	TX	B1	TRTDRTRG	Treatment Duration target	4
					TRTDRTOL	Treatment Duration Tolerance	.25
??	123	MNvit	TX	B1	TRTDURU	Treatment Duration Unit (this is for both TRTDURT, TRTDURTOL)	H
	123	MNvit	TX	B1	PRDCONC	Concentration of product	0
	123	MNvit	TX	B1	PRDCONCU	Concentration Unit	ug/ml
	123	MNvit	TX	B1	Product	Product Name
	123	MNvit	TX	B1		Smoking Regime
	123	MNvit	TX	B1		Smoke Fraction
	123	MNvit	TX	C1	METACT	Metabolic Activation	-S9
	123	MNvit	TX	C1	TRTDUR	Treatment Duration	24
??	123	MNvit	TX	C1	TRTDURU	Treatment Duration Unit	H
	123	MNvit	TX	C1	PRDCONC	Concentration of product	0
	123	MNvit	TX	C1	PRDCONCU	Concentration Unit	ug/ml
	123	MNvit	TX	C1	Product	Product Name
	123	MNvit	TX	C1		Smoking Regime
	123	MNvit	TX	C1		Smoke Fraction

Expand

title	gt.xpt (similar to LB)

Row	STUDYID	ASSAYID	DOMAIN	TXCD	GTSEQ	GTTESTCD	GTTEST	GTCELLEV (cells evaluated)	GTORRES	GTORRESU	GTSTRESC	GTSTRESN	GTSTRESU	GTDTC
				A6	1	RICC
					2	...
					8	AVGREL
1	123	MNvit	GT	A2	1	RICC		134	15.7	%	15.7	15.7	%	2022-05-25
2	123	MNvit	GT	A2	2	RCC		134	13.0	%	13.0	13.0	%	2022-05-25
3	123	MNvit	GT	A2	3	RPD		134	7.9	%	7.9	7.9	%	2022-05-25
4	123	MNvit	GT	A2	4	MNCELLS	Micronucleated Cells	3266	20	Cells	20	20	Cells	2022-05-25
5	123	MNvit	GT	A2	5	MNCELLS	Micronucleated Cells	2190	17	Cells	17	17	Cells	2022-05-25
6	123	MNvit	GT	A2	6	MNCELLS	Micronucleated Cells	2758	13	Cells	13	13	Cells	2022-05-25
7	123	MNvit	GT	A2	7	MNCELLS	Micronucleated Cells	2714	21	Cells	21	21	Cells	2022-05-25
8	123	MNvit	GT	A2	8	AVGREL	Average Relative MN Frequency		0.66	%	0.66	0.66	%	2022-05-25
9	123	MNvit	GT	A1	1	RICC		154	0	%	0	0	%	2022-05-25
10	123	MNvit	GT	A1	2	RCC		154	0	%	0	0	%	2022-05-25
11	123	MNvit	GT	A1	3	RPD		154	0	%	0	0	%	2022-05-25
12	123	MNvit	GT	A1	4	MNCELLS	Micronucleated Cells	3266	15	Cells	15	15	Cells	2022-05-25
13	123	MNvit	GT	A1	5	MNCELLS	Micronucleated Cells	2190	13	Cells	13	13	Cells	2022-05-25
14	123	MNvit	GT	A1	6	MNCELLS	Micronucleated Cells	2758	17	Cells	17	17	Cells	2022-05-25
15	123	MNvit	GT	A1	7	MNCELLS	Micronucleated Cells	2714	12	Cells	12	12	Cells	2022-05-25
16	123	MNvit	GT	A1	8	AVGREL	Average Relative MN Frequency		0.57	%	0.57	0.57	%	2022-05-25

...

Page tree

Versions Compared

Old Version 31

New Version 32

Key